Implementing an evidence-based parenting program in community agencies: what helps and what gets in the way?

Adm Policy Ment Health

School of Psychology, University of Ottawa, 136 Jean Jacques Lussier, Ottawa, ON, K1N 6N5, Canada.

Published: November 2012

Adoption of evidence-based programs for families by community agencies requires an understanding of variables that influence implementation. Managers and service providers from 64 community agencies reported on variables that affected the implementation of Triple P, an evidence-based parenting program. Both types of stakeholders reported adequate office resources; over half the managers and over two-thirds of service providers reported adequate training. Adequate office resources and positive agency characteristics, including organizational climate, were associated with higher program usage. Service providers' reports of the variables impacted their individual adherence rates; managers had broader perspectives of the quality of implementation in their organizations.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10488-011-0371-yDOI Listing

Publication Analysis

Top Keywords

community agencies
12
evidence-based parenting
8
parenting program
8
service providers
8
reported adequate
8
adequate office
8
office resources
8
implementing evidence-based
4
program community
4
agencies helps
4

Similar Publications

Objectives: To explore husbands' views on breast cancer screening, risk-based screening and their role in influencing their wives' health-seeking behaviours.

Design: Qualitative focus group discussion (FGD) supplemented by quantitative data from a cohort study using a structured questionnaire.

Setting: This study was conducted in a community-based setting, with participants recruited online through non-profit organisations via social media and email.

View Article and Find Full Text PDF

The HPCDP Journal: celebrating a decade of impact.

Health Promot Chronic Dis Prev Can

March 2025

Public Health Agency of Canada, Ottawa, Ontario, Canada.

Health Promotion and Chronic Disease Prevention in Canada (the HPCDP Journal) is uniquely positioned to serve diverse audiences by presenting valuable contributions to the field of public health from scientists within and outside of government. The HPCDP Journal marking its 10th anniversary under the current name is an opportune time to reflect on how far the journal, the editorial team and the community of contributors have come.

View Article and Find Full Text PDF

Individualized Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% Administration in Chronic Inflammatory Demyelinating Polyradiculoneuropathy: The Nurse's Role.

J Infus Nurs

March 2025

Author Affiliations: Takeda Development Center Americas, Inc., Cambridge, Massachusetts (Kim Duff); IQVIA Clinical Research Organization, Milan, Italy (Arianna Soresini); IQVIA Clinical Research Organization, Cambridge, Massachusetts (Nancy Wolf* and Alane Fairchild); IQVIA Clinical Research Organization, Ankara, Turkey (Şükran Altan**); IQVIA Clinical Research Organization, Mexico City, Mexico (Wendy Bencomo); University Clinical Center of Serbia, Belgrade, Serbia (Ivana Ivankovic); University Health Network, University of Toronto, Toronto, Ontario, Canada (Evelyn Sarpong); IQVIA Clinical Research Organization, Warsaw, Poland (Anna Kuczkowska).

Hyaluronidase-facilitated subcutaneous immunoglobulin (fSCIG) 10% offers potential improvements in patient independence and tolerability versus intravenous immunoglobulin (IVIG) when used for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). fSCIG 10% also requires less frequent infusions and fewer infusion sites than conventional subcutaneous immunoglobulin (subcutaneous immunoglobulin without hyaluronidase). The ADVANCE-CIDP 1 study demonstrated fSCIG 10% efficacy and safety in preventing CIDP relapse and positive responses from patients in terms of satisfaction and treatment preference.

View Article and Find Full Text PDF

In Vitro Activity of Bacteriophages Against Ocular Methicillin-resistant S. aureus Isolates Collected in the US.

Ophthalmol Ther

March 2025

Team "Staphylococcal Pathogenesis", CIRI - Centre International de Recherche en Infectiologie, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Lyon, France.

Introduction: Methicillin-resistant Staphylococcus aureus (MRSA) is a leading cause of sight-threatening infections in the US. These strains pose a significant challenge in managing ocular infections, as they frequently exhibit resistance to first-line empirical antibiotics. To assess the potential of bacteriophages as innovative topical therapies for treatment of recalcitrant ocular infections, we evaluated the in vitro antimicrobial activity of a set of anti-S.

View Article and Find Full Text PDF

A toolkit to implement opioid quality improvement efforts in primary care: Findings from a mixed-methods study.

J Opioid Manag

March 2025

Abt Global, LLC, Cambridge, Mas-sachusetts. ORCID: https://orcid.org/0000-0003-3391-2041.

Objective: The Six Building Blocks: A Team-Based Approach to Improving Opioid Management in Primary Care (6BBs) program provides a roadmap for improving the management of patients on opioid therapy for chronic pain. The goal of this project was to evaluate the How-to-Implement Toolkit (Toolkit) for clinics to independently implement the 6BBs without a practice facilitator.

Methods: Eight healthcare organizations with 62 clinics participated in the program.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!